Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-g...
Quantum-Si rallied during the regular session, advancing 5.5% to $0.9749 by 09:47 ET, driven by strong pre-market momentum that saw a 7.62% rise (high $0.9450) carry into normal trading, largely pricing in CEO Jeffrey Alan Hawkins' combined ~23,460-share sell-off. Q1 FY2026 revenue plunged 69.36% YoY to $258K, with net loss widening 12.93% to $21.67M. The stock trades 68.39% below its 52-week high of $3.10 and 41.77% above its low of $0.6912, with a PB of 1.06x, below the 60-day MA of $0.967 but above the 20-day MA of $0.957, while YTD decline stands at 15.53%. Still, the company recently signed a 10-year lease for a 54,374-sq-ft San Diego facility and initiated Proteus prototype customer testing and roadshow activities.
Quantum-Si to join H.C. Wainwright Global Investment Conference fireside chat
A week of pivots: How legacy giants and struggling startups are bracing for impact
Quantum-Si Q2 FY26 net loss narrows to $23.53 million; revenue drops 41.79% to $344,000
Structural Divergence Across US Sectors: AI Infrastructure Spinoffs and Consumer Contraction
Noah, AES Lead Capital Deployment Push Across Niche Sectors
Quantum-Si (QSI) to Release Earnings on Tuesday